PDS Biotechnology
PDSB
PDSB
56 hedge funds and large institutions have $16.5M invested in PDS Biotechnology in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
57% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 21
75% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 24
Holders
56
Holding in Top 10
–
Calls
$1.35M
Puts
$278K
Top Buyers
| 1 | +$431K | |
| 2 | +$253K | |
| 3 | +$182K | |
| 4 |
SPA
Sherbrooke Park Advisers
White Plains,
New York
|
+$153K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$142K |
Top Sellers
| 1 | -$930K | |
| 2 | -$563K | |
| 3 | -$562K | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$418K |
| 5 |
Jane Street
New York
|
-$334K |